Lundbeck CEO joins board of directors at Syros Pharmaceuticals

Deborah Dunsire, CEO at Lundbeck, has been appointed to the board of directors at Syros Pharmaceuticals.
Photo: Gregers Tycho/Ritzau/Ritzau Scanpix
Photo: Gregers Tycho/Ritzau/Ritzau Scanpix
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY DANIEL PEDERSEN

A fresh face has joined the board at the US-based biopharmaceutical company Syros Pharmaceuticals in the form of Deborah Dunsire, CEO at Lundbeck, a press release reveals.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading